Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fungi Perfecti
Shelton, Washington, United Statesfungi.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
Fungi Perfecti is a commercial-stage mycology company. While primarily known for nutraceuticals, they have participated in NIH-funded clinical trials, notably a Phase 1 study showing that Turkey Tail (Trametes versicolor) mushroom mycelium supports the immune system in women with breast cancer after standard medical treatment.
- Therapeutic areas
- OncologyImmunologyNeurologyOther
- Modalities
- Microbial therapyNatural productsSmall moleculeBiologic
- Industry
- Biotech
02
Partnerships
Washington State UniversityNational Institutes of HealthUnited States Department of Defense
Beyond the preview
Go deeper on Fungi Perfecti.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fungi Perfecti.